[Michael DeVries]

My new #MachineLearning Model currently Predicts that $BVSN will be Up >= 10%, from @$1.00, within one (1) month!

#BroadVision #Internet #Software #Stock #Predictions #ArtificialIntelligence #AI #ML #StockPicking #Stocks

Disclaimer

[Michael DeVries]

My new #MachineLearning Model currently Predicts that $CFMS will be Up >= 10%, from @$0.36, within one (1) month!

#Conformis #Medical #3DPrinting #Stock #Predictions #ArtificialIntelligence #AI #ML #StockPicking #Stocks

Disclaimer

[Michael DeVries]

My Hypotheses for Trading for the remainder of 2018:

1) Continued Tax Loss Selling of 2018 Losers

2) Short Sellers won’t cover until > 1/1/19

3) => 2018 Losers continue to Lose until >= 1/2/19

4) BioTechs continue to slide down => Wait until >= 1/2/19 to Buy those Trading Below Book and/or Trading Below Cash with Near Term Catalysts

5) Companies will Buy Back as much of their own stock at these low / bottom prices at possible … will this provide a “floor”/stable bottom for Stocks with Buy Backs?

6) Companies with excess Cash, e.g. Repatriating cash, will “scoop up” value stocks/companies currently trading undervalued/cheap

What do you all think about those Hypotheses?

What are your (additional) Hypotheses for Trading for the remainder of 2018?

How might we profitably trade these hypotheses for the remainder of 2018?

Let’s talk about it all herein, ok?

I hope this all helps!

Good Luck! and Have a Great rest of 2018 Trading Year!

– Michael S. DeVries

[Michael DeVries]

Articles – 20181217 – 1:
1) Today’s Deep Learning “AI” Is Machine Learning Not Magic => https://www.forbes.com/sites/kalevleetaru/2018/11/14/todays-deep-learning-ai-is-machine-learning-not-magic/#678784d96875
2) 10 Free Must-See Courses for Machine Learning and Data Science => https://www.kdnuggets.com/2018/11/10-free-must-see-courses-machine-learning-data-science.html
3) Top 5 Data Science and Machine Courses to Learn Online – Best of Lot => https://javarevisited.blogspot.com/2018/03/top-5-data-science-and-machine-learning-online-courses-to-learn-online.html
4) Ultimate Guide to Data Science Courses (Over 65+ courses covered) => https://www.upnxtblog.com/index.php/2018/11/28/ultimate-guide-to-data-science-courses-over-65-courses-covered/
5) How to cut through the AI hype to become a machine learning engineer => https://medium.freecodecamp.org/how-to-cut-through-the-ai-hype-to-become-a-machine-learning-engineer-b0d2c5e4ae02
a. See for more Courses?
6) 10 must-watch movies on Data Science and Machine Learning => https://bigdata-madesimple.com/10-must-watch-movies-data-science-machine-learning/
7) Machine Learning and Its Impact to Software Development => https://www.softwaretestpro.com/machine-learning-and-its-impact-to-software-development/
8) The Future of Data Science => https://towardsdatascience.com/the-future-of-data-science-14653afb52f5
9) Machine Learning in Organization: First Steps => https://martinhiesboeck.com/2018/08/08/machine-learning-in-organization-first-steps/
10) Automated Machine Learning vs Automated Data Science => https://www.kdnuggets.com/2018/07/automated-machine-learning-vs-automated-data-science.html
a. Good Process Models
11) The Data Science Puzzle, Explained => https://www.kdnuggets.com/2016/03/data-science-puzzle-explained.html/2
a. Good Diagrams
12) Intro to Data Science for Managers [Mindmap] => https://medium.com/activewizards-machine-learning-company/data-science-for-managers-mindmap-bb95bedc3154
a. Good Mindmap of branches
13) Dean of Big Data’s Favorite Infographic Picks of 2018 => https://www.datasciencecentral.com/profiles/blogs/dean-of-big-data-s-favorite-infographic-picks-of-2018
14) 10 Free Must-Read Machine Learning E-Books For Data Scientists & AI Engineers => https://www.analyticsvidhya.com/blog/2018/02/10-free-must-read-machine-learning-e-books/
15) 10 New Specializations and Courses in Cutting-Edge Topics | Coursera Blog
16) blog.coursera.org – Shared by devLatino
17) Here’s a roundup of new Specializations and courses on Coursera, brought to you by top universities and leading companies from all over the world. Learn foundational data science skills from IBM, mac…
18) 65 Free Data Science Resources for Beginners => https://elitedatascience.com/data-science-resources
19) Big Data-An Opportunity For Businesses! => https://www.linkedin.com/pulse/big-data-an-opportunity-businesses-sneha-chakraborty/
20) How To Extract Business Value From Data Science: It’s All About The Teamwork => https://www.linkedin.com/pulse/how-extract-business-value-from-data-science-its-all-teamwork-mathew/
21) RPA’s ticking time bomb: enterprises and service providers must make RPA talent their top priority to avoid disaster => https://www.hfsresearch.com/pointsofview/rpas-ticking-time-bomb-enterprises-and-service-providers-must-make-rpa-talent-their-top-priority-to-avoid-disaster

[Michael DeVries]

#Bullish #Stocks currently #TradingBelowBook (#TBB ) as of 12/14/2018 include:

1. $ADXS – Advaxis, Inc. :
   1. Book/sh = $0.63
2. $ATOS – Atossa Genetics Inc. :
   1. Book/sh = $1.98
3. $CFMS – Conformis, Inc. :
   1. Book/sh = $0.72
4. $CHFS – CHF Solutions, Inc. :
   1. Book/sh = $1.38
5. $CLDX – Celldex Therapeutics, Inc. :
   1. Book/sh = $0.78
6. $CYCC – Cyclacel Pharmaceuticals, Inc. :
   1. Book/sh = $1.38
7. $DCAR – DropCar, Inc. :
   1. Book/sh = $1.15
8. $DTEA – DAVIDsTEA Inc. :
   1. Book/sh = $2.65
9. $GSAT – Globalstar, Inc. :
   1. Book/sh = $0.30
10. $HMNY – Helios and Matheson Analytics Inc. :
    1. Book/sh = $113.81
11. $IPWR – Ideal Power Inc. :
    1. Book/sh = $0.46
12. $JAGX – Jaguar Health, Inc. :
    1. Book/sh = $1.23
13. $KOOL – Cesca Therapeutics Inc. :
    1. Book/sh = $0.70
14. $MBOT – Microbot Medical Inc. :
    1. Book/sh = $2.23
15. $OMED – OncoMed Pharmaceuticals, Inc. :
    1. Book/sh = $1.34
16. $OSN – Ossen Innovation Co., Ltd. :
    1. Book/sh = $15.50
17. $OXBR – Oxbridge Re Holdings Limited :
    1. Book/sh = $2.57
18. $RTTR – Ritter Pharmaceuticals, Inc. :
    1. Book/sh = $1.32
19. $TCON – TRACON Pharmaceuticals, Inc. :
    1. Book/sh = $1.24
20. $TISA – Top Image Systems Ltd. :
    1. Book/sh = $0.78
21. $TRVN – Trevena, Inc. :
    1. Book/sh = $0.63
22. $VBLT – Vascular Biogenics Ltd. :
    1. Book/sh = $2.03
23. $VXRT – Vaxart, Inc. :
    1. Book/sh = $3.13
24. $XGTI – xG Technology, Inc. :
    1. Book/sh = $0.58

Please also Share Your Favorite Stocks currently Trading Below Book (TBB) here in this Topic as well, ok?

#StockPicks #Stock #Market #Trading

[Michael DeVries]

Bullish Stocks currently Trading Below Cash (TBC) as of 12/14/2018 include:

1. $ADXS – Advaxis, Inc. :
   1. Cash/sh = $0.54
2. $ATOS – Atossa Genetics Inc. :
   1. Cash/sh = $1.71
3. $CFMS – Conformis, Inc. :
   1. Cash/sh = $0.55
4. $CHFS – CHF Solutions, Inc. :
   1. Cash/sh = $1.17
5. $CLDX – Celldex Therapeutics, Inc. :
   1. Cash/sh = $0.59
6. $CUR – Neuralstem, Inc. :
   1. Cash/sh = $0.45
7. $CYCC – Cyclacel Pharmaceuticals, Inc. :
   1. Cash/sh = $1.53
8. $DCAR – DropCar, Inc. :
   1. Cash/sh = $0.35
9. $IPWR – Ideal Power Inc. :
   1. Cash/sh = $0.41
10. $MBOT – Microbot Medical Inc. :
    1. Cash/sh = $2.17
11. $OMED – OncoMed Pharmaceuticals, Inc. :
    1. Cash/sh = $1.75
12. $OXBR – Oxbridge Re Holdings Limited :
    1. Cash/sh = $1.32
13. $RTTR – Ritter Pharmaceuticals, Inc. :
    1. Cash/sh = $2.17
14. $TCON – TRACON Pharmaceuticals, Inc. :
    1. Cash/sh = $1.79
15. $TRVN – Trevena, Inc. :
    1. Cash/sh = $0.94
16. $VBLT – Vascular Biogenics Ltd. :
    1. Cash/sh = $1.71
17. $VXRT – Vaxart, Inc. :
    1. Cash/sh = $2.96

Please also Share Your Favorite Stocks currently Trading Below Cash (TBC) here in this Topic as well, ok?

#TradingBelowCash #TBC #StockPicks #Stock #Market #Trading

[Michael DeVries]

The following are the Stock Symbols on my Watchlist to Buy if/when they bottom out at the Buy at Price Targets listed below for the Week of 12/17/2018 – 12/21/2018:

1) ACHV – Achieve Life Sciences, Inc. – Trading Below Cash
a. Buy at < ~ $1.32
b. Sell at >~ $5.20
c. Catalysts:
1. Phase 2 – Trial of Cytisine in Adult Smokers; 20190512; 20190630; https://ClinicalTrials.gov/show/NCT03709823

2) ARCW – ARC Group Worldwide, Inc.
a. Buy at < ~ $0.91
b. Sell at >~ $2.60

3) NNDM – Nano Dimension Ltd.
a. Buy at < ~ $1.21
b. Sell at >~ $3.35

4) LIFE – aTyr Pharma, Inc. – Trading Below Cash
a. Buy at < ~ $0.45
b. Sell at >~ $0.82
c. Catalysts:
1. In the fourth quarter of 2018, aTyr plans to initiate a Phase 1b/2a multiple-ascending dose, placebo-controlled, first-in-patient study with ATYR1923 …; 20181001; 20181231; https://finance.yahoo.com/news/atyr-pharma-announces-pulmonary-sarcoidosis-200500950.html

5) KOPN – Kopin Corporation
a. Buy at < ~ $1.37
b. Sell at >~ $1.95

What do you think about these Stock Picks to Buy at these Price Targets?

What other Stock Symbols do you all think are the Best Stocks < ~ $10 to Buy next week, 12/17/2018 – 12/21/2018, and Why?

Disclaimer

[Michael DeVries]

Walmart is testing a robot fry cook named ‘Flippy’ at its delis => https://finance.yahoo.com/news/exclusive-walmart-testing-robot-fry-cook-delis-154733360.html

What do you think about that?

What do you predict will be the next jobs in mainstream food service, restaurants, etc. to be replaced by robots?

Let’s talk about it all herein, ok?

[Michael DeVries]

Walmart to deploy hundreds of robot janitors => https://seekingalpha.com/news/3414158-walmart-deploy-hundreds-robot-janitors?ifp=0

What do you think about that?

What do you predict will be the next jobs in mainstream retail to be replaced by robots?

Let’s talk about it all herein, ok?

[Michael DeVries]

The following are the Stock Symbols on my Watchlist to Buy if/when they bottom out at the Buy at Price Targets listed below for the Week of 12/03/2018 – 12/07/2018:

1) ACHV – Achieve Life Sciences, Inc. – Trading Below Cash
a. Buy at < ~ $1.51
b. Sell at >~ $5.20
c. Catalysts:
1. Phase 2 – Trial of Cytisine in Adult Smokers; 20190512; 20190630; https://ClinicalTrials.gov/show/NCT03709823

2) ARCW – ARC Group Worldwide, Inc.
a. Buy at < ~ $1.05
b. Sell at >~ $2.60

3) LIFE – aTyr Pharma, Inc. – Trading Below Cash
a. Buy at < ~ $0.49
b. Sell at >~ $0.82
c. Catalysts:
1. In the fourth quarter of 2018, aTyr plans to initiate a Phase 1b/2a multiple-ascending dose, placebo-controlled, first-in-patient study with ATYR1923 …; 20181001; 20181231; https://finance.yahoo.com/news/atyr-pharma-announces-pulmonary-sarcoidosis-200500950.html

4) KOPN – Kopin Corporation
a. Buy at < ~ $1.54
b. Sell at >~ $1.95

What do you think about these Stock Picks to Buy at these Price Targets?

What other Stock Symbols do you all think are the Best Stocks < ~ $10 to Buy next week, 12/03/2018 – 12/07/2018, and Why?

Disclaimer

[Michael DeVries]

The following are the some More FREE training courses on topics including Machine Learning (ML), Deep Learning (DL), Data Science, Big Data, etc.:

• MIT Open Course Ware => https://ocw.mit.edu/courses/electrical-engineering-and-computer-science/6-0002-introduction-to-computational-thinking-and-data-science-fall-2016/lecture-videos/lecture-11-introduction-to-machine-learning/
• https://www.youtube.com/watch?v=uXt8qF2Zzfo
• Training on Machine Learning with AWS => ​https://aws.amazon.com/training/learning-paths/machine-learning/

Please add any other good, FREE training courses on topics including Machine Learning (DL), Deep Learning (DL), Data Science, Big Data, etc. here, ok?

I hope this all helps and Have a Great Day!

– Michael S. DeVries

[Michael DeVries]

The following are the Stock Symbols on my Watchlist to Buy if/when they bottom out at the Buy at Price Targets listed below for the Week of 11/26/2018 – 11/30/2018:

1) ACHV – Achieve Life Sciences, Inc. – Trading Below Cash
a. Buy at < ~ $1.53
b. Sell at >~ $5.20
c. Catalysts:
1. NA – In Vitro And Ex Vivo Anti-Inflammatory Activities Of Salmon Polar Lipids; 20181031; 20181130; https://ClinicalTrials.gov/show/NCT03603769
2. Phase 2 – Trial of Cytisine in Adult Smokers; 20190512; 20190630; https://ClinicalTrials.gov/show/NCT03709823

2) OXBR – Oxbridge Re Holdings Limited – Trading Below Cash
a. Buy at < ~ $0.93
b. Sell at >~ $2.50

3) ADXS – Advaxis, Inc. – Trading Below Cash
a. Buy at < ~ $0.42
b. Sell at >~ $1.15
c. Catalysts:
1. Phase 1Phase 2 – ADXS11-001 High Dose HPV+ Cervical Cancer; 20181201; 20181231; https://ClinicalTrials.gov/show/NCT02164461
2. Phase 2 – A Study of Pemetrexed Maintenance With or Without ADXS11-001 Immunotherapy in Patients With Human Papillomavirus Positive (HPV+), NSCLC Following First-Line Induction Chemotherapy; 20190301; 20190331; https://ClinicalTrials.gov/show/NCT02531854
3. Phase 1Phase 2 – Dose Escalation Study of ADXS31-164 in Subjects With HER2 Expressing Solid Tumors; 20180801; 20181231; https://ClinicalTrials.gov/show/NCT02386501
4. Phase 2 – ADXS 11-001 Vaccination Prior to Robotic Surgery, HPV-Positive Oropharyngeal Cancer; 20180801; 20190831; https://ClinicalTrials.gov/show/NCT02002182
5. Phase 1Phase 2 – ADXS31-142 Alone and in Combination With Pembrolizumab (MK-3475) in Patients With Prostate Cancer – KEYNOTE-046; 20190401; 20191231; https://ClinicalTrials.gov/show/NCT02325557
6. Phase 2 – Phase 2 Study of ADXS11-001 in Subjects With Carcinoma of the Anorectal Canal; 20200301; 20220331; https://ClinicalTrials.gov/show/NCT02399813
7. Phase 3 – Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer; 20200601; 20210630; https://ClinicalTrials.gov/show/NCT02853604
8. Phase 1Phase 2 – Phase 1-2 Study of ADXS11-001 or MEDI4736 Alone or Combo In Cervical or HPV+ Head & Neck Cancer; 20190701; 20191231; https://ClinicalTrials.gov/show/NCT02291055
9. Phase 1 – Expressing Personalized Tumor Antigens Study; 20190901; 20200930; https://ClinicalTrials.gov/show/NCT03265080

4) OMED – OncoMed Pharmaceuticals, Inc. – Trading Below Cash
a. Buy at < ~ $1.31
b. Sell at >~ $3.25
c. Catalysts:
1. Phase 1 – A Study of OMP-313M32 in Subjects With Locally Advanced or Metastatic Solid Tumors; 20190501; 20191031; https://ClinicalTrials.gov/show/NCT03119428
2. Phase 1 – A Study of OMP-305B83 in Subjects With Metastatic Colorectal Cancer; 20190101; 20190131; https://ClinicalTrials.gov/show/NCT03035253
3. Phase 1 – A Study of OMP-336B11 in Subjects With Locally Advanced or Metastatic Tumors; 20191201; 20200630; https://ClinicalTrials.gov/show/NCT03295942
4. Phase 1 – A Phase 1b Study of OMP-305B83 Plus Paclitaxel in Subjects With Ovarian, Peritoneal or Fallopian Tube Cancer; 20190601; 20191231; https://ClinicalTrials.gov/show/NCT03030287

5) EDGE – Edge Therapeutics, Inc. – Trading Below Cash
a. Buy at < ~ $0.65
b. Sell at >~ $1.18
c. Catalysts:
1. Phase 3 – Antimicrobial Barrier Dressing Versus Closed-incision Negative Pressure Therapy in the Obese Primary Total Joint Arthroplasty; 20181201; 20181231; https://ClinicalTrials.gov/show/NCT03345771
2. Phase 3 – Comparative Study to Evaluate the Effectiveness of Atenolol and Propranolol in the Treatment of Infantile Hemangiomas; 20181201; 20181231; https://ClinicalTrials.gov/show/NCT03237637
3. NA – Clinical Trial Investigating the Combination Therapy With Luminor DCB and iVolution Stent in TASC C and D Femoropopliteal Lesions; 20181231; 20191231; https://ClinicalTrials.gov/show/NCT03347383
4. Phase 2 – Effect of Corticosteroids on Inflammation at the Edge of Acute Multiple Sclerosis Plaques; 20190131; 20200601; https://ClinicalTrials.gov/show/NCT02784210
5. NA – Treatment Outcomes of MicroPulse Trans-scleral Cyclophotocoagulation in Uncontrolled Glaucoma; 20190101; 20190131; https://ClinicalTrials.gov/show/NCT03187418
6. NA – Stereotactic Body Radiation Therapy in Stage II/III Non Small Cell Lung Cancer; 20180701; 20181231; https://ClinicalTrials.gov/show/NCT01657617
7. NA – Low-level Laser Therapy Versus High Frequency on Pressure Ulcers Treatment; 20171201; 20181231; https://ClinicalTrials.gov/show/NCT02296697
8. Phase 3 – An Efficacy and Safety Study of Grazoprevir (MK-5172) + Elbasvir (MK-8742) in the Treatment of Chronic Hepatitis C Virus (HCV) Genotype (GT)1, 4, or 6 Infection in Treatment-Naïve Participants Who Are on Opiate Substitution Therapy (MK-5172-062); 20150610; 20181208; https://ClinicalTrials.gov/show/NCT02105688
9. – Restorelle® Mesh Versus Native Tissue Repair for Prolapse; 20180501; 20211130; https://ClinicalTrials.gov/show/NCT02162615
10. NA – Low-level Light Therapy on Treatment of Venous Ulcers Assesed by Nursing Outcome Classification (NOC); 20180701; 20181231; https://ClinicalTrials.gov/show/NCT03229330
11. NA – A New Treatment for Zenkers Diverticulum-submucosal Tunneling Endoscopic Septum Division; 20180614; 20190514; https://ClinicalTrials.gov/show/NCT03125733
12. NA – Assessment of Chiropractic Treatment: Strength and Balance; 20190201; 20190228; https://ClinicalTrials.gov/show/NCT02670148
13. NA – Word Learning in Children With Autism; 20210531; 20210531; https://ClinicalTrials.gov/show/NCT03419611
14. – GIse Registry Of Transcatheter Treatment of Mitral Valve regurgitaTiOn (GIOTTO); 20210201; 20210201; https://ClinicalTrials.gov/show/NCT03521921
15. NA – Systematic Light Exposure to Treat Cancer-Related Fatigue; 20220430; 20220430; https://ClinicalTrials.gov/show/NCT03217201
16. – A Trial on the Opportunity and Treatment of Residual Deformity After Reduction in Developmental Dislocation of the Hip; 20241201; 20241231; https://ClinicalTrials.gov/show/NCT02163603
17. Phase 1 – Dual-Energy CT on Plan Quality, Dose-delivery Accuracy, and Simulated Patient Outcomes for Locally Advanced Lung and Brain Tumor Patients Treated With Proton Therapy; 20220531; 20220531; https://ClinicalTrials.gov/show/NCT03403361
18. NA – A Multicenter Trial of PLA vs. Surgery for Treating PTMC; 20201231; 20221231; https://ClinicalTrials.gov/show/NCT03377829
19. NA – Above-versus Below-elbow Casting for Conservative Treatment of Distal Radius Fractures; 20190402; 20191215; https://ClinicalTrials.gov/show/NCT03126175
20. – PET-MRI F-DOPA Activity in the Mesocorticolimbic System and Depressive Symptoms in the Prediction of Treatment Compatibility; 20190301; 20190331; https://ClinicalTrials.gov/show/NCT03026309
21. NA – Light Therapy and Binge Eating Disorder Treatment (BED Light Study); 20191029; 20191029; https://ClinicalTrials.gov/show/NCT03094260
22. – Negative Pressure Wound Therapy Registry; 20200101; 20200131; https://ClinicalTrials.gov/show/NCT02467998
23. – Effect of miR-200b on Diabetic Wounds; 20191201; 20201231; https://ClinicalTrials.gov/show/NCT02581098

6) LIFE – aTyr Pharma, Inc. – Trading Below Cash
a. Buy at < ~ $0.49
b. Sell at >~ $0.82
c. Catalysts:
1. In the fourth quarter of 2018, aTyr plans to initiate a Phase 1b/2a multiple-ascending dose, placebo-controlled, first-in-patient study with ATYR1923 …; 20181001; 20181231; https://finance.yahoo.com/news/atyr-pharma-announces-pulmonary-sarcoidosis-200500950.html

What do you think about these Stock Picks to Buy at these Price Targets?

What other Stock Symbols do you all think are the Best Stocks < ~ $10 to Buy next week, 11/26/2018 – 11/30/2018, and Why?

Disclaimer

[Michael DeVries]

Please find some Great Resources, Training, Events, News, etc. regarding Robotic Process Automation (RPA) in Ed Garabedian‘s RPASuccss.com site at: https://rpasuccess.com/

I have recently met and taken some in person Blue Prism training from Ed Garabedian and found him to be knowledgeable and experienced regarding Blue Prism and Robotic Process Automation (RPA) and therefore, I can recommend Ed as a Blue Prism trainer.

I hope this all helps and Have a Great Day!

– Michael S. DeVries

[Michael DeVries]

The following are the start of a list of FREE training courses on topics including Machine Learning (DL), Deep Learning (DL), Data Science, Big Data, etc.:

• Every single Machine Learning course on the internet, ranked by your reviews => https://medium.freecodecamp.org/every-single-machine-learning-course-on-the-internet-ranked-by-your-reviews-3c4a7b8026c0
• Jeremy Howard offers free ML and DL courses. I have not finished either, but I’ve found the content interesting.
  • https://www.fast.ai/
    • ML: https://course.fast.ai/ml.html
    • DL, Part 1: https://course.fast.ai/lessons/lesson1.html
    • DL, Part 2: https://course.fast.ai/part2.html
• Data Science for Beginners => https://docs.microsoft.com/en-us/azure/machine-learning/studio/data-science-for-beginners-the-5-questions-data-science-answers

Please add any other good, FREE training courses on topics including Machine Learning (DL), Deep Learning (DL), Data Science, Big Data, etc. here, ok?

I hope this all helps and Have a Great Day!

– Michael S. DeVries

[Michael DeVries]

#Bullish #Stocks currently #TradingBelowBook (#TBB ) as of 11/16/2018 include:

1. $ATOS – Atossa Genetics Inc. :
   1. Book/sh = $1.98
2. $CFMS – Conformis, Inc. :
   1. Book/sh = $0.82
3. $CHFS – CHF Solutions, Inc. :
   1. Book/sh = $1.96
4. $CLDX – Celldex Therapeutics, Inc. :
   1. Book/sh = $0.87
5. $CYCC – Cyclacel Pharmaceuticals, Inc. :
   1. Book/sh = $1.55
6. $DCAR – DropCar, Inc. :
   1. Book/sh = $1.15
7. $DTEA – DAVIDsTEA Inc. :
   1. Book/sh = $2.65
8. $HMNY – Helios and Matheson Analytics Inc. :
   1. Book/sh = $113.81
9. $IPWR – Ideal Power Inc. :
   1. Book/sh = $0.60
10. $JAGX – Jaguar Health, Inc. :
    1. Book/sh = $1.23
11. $KOOL – Cesca Therapeutics Inc. :
    1. Book/sh = $0.67
12. $LIFE – aTyr Pharma, Inc. :
    1. Book/sh = $1.52
13. $OSN – Ossen Innovation Co., Ltd. :
    1. Book/sh = $15.50
14. $OVAS – OvaScience, Inc. :
    1. Book/sh = $1.40
15. $RTTR – Ritter Pharmaceuticals, Inc. :
    1. Book/sh = $2.11
16. $RXII – RXi Pharmaceuticals Corporation :
    1. Book/sh = $0.80
17. $TISA – Top Image Systems Ltd. :
    1. Book/sh = $0.78
18. $TNXP – Tonix Pharmaceuticals Holding Corp. :
    1. Book/sh = $1.43
19. $VBLT – Vascular Biogenics Ltd. :
    1. Book/sh = $2.03
20. $VXRT – Vaxart, Inc. :
    1. Book/sh = $3.13
21. $XGTI – xG Technology, Inc. :
    1. Book/sh = $0.69

Please also Share Your Favorite Stocks currently Trading Below Book (TBB) here in this Topic as well, ok?

#StockPicks #Stock #Market #Trading

[Michael DeVries]

The next Big Data Florida meeting is Monday, November 19, 2018, at 6:00 p.m. Tauhida Parveen will be speaking about “How to Become a Data Scientist“:

Would you like to become
a data scientist? It’s one of the hottest professions in the world.
As a data scientist, you’ll be in great demand, earn an excellent
salary, and work on some of the most interesting problems facing
society today. Sounds great! So, what’s the catch?

It’s not easy — but
nothing worthwhile ever is.

Do you need to be good
at math? (Some of it, yes.) Do you need to be a good programmer?
(It helps.) Do you need to be a good communicator? (Absolutely.)
Fortunately, these are all skills you can learn. Come to this
informative talk by Tauhida Parveen to learn about what it really
takes to become a data scientist. 

 

Meetings take place in Room 204 (Link Multimedia Room) of the Evans Library on the campus of the Florida
Institute of Technology.

See you next Monday!

Regards,

Scott Tilley
President
Big Data Florida
http://www.BigDataFlorida.org

[Michael DeVries]

Bullish Stocks currently Trading Below Cash (TBC) as of 11/16/2018 include:

1. $ATOS – Atossa Genetics Inc. :
   1. Cash/sh = $1.71
2. $CFMS – Conformis, Inc. :
   1. Cash/sh = $0.73
3. $CLDX – Celldex Therapeutics, Inc. :
   1. Cash/sh = $0.69
4. $CYCC – Cyclacel Pharmaceuticals, Inc. :
   1. Cash/sh = $1.65
5. $IPWR – Ideal Power Inc. :
   1. Cash/sh = $0.49
6. $LIFE – aTyr Pharma, Inc. :
   1. Cash/sh = $2.00
7. $OVAS – OvaScience, Inc. :
   1. Cash/sh = $1.45
8. $RTTR – Ritter Pharmaceuticals, Inc. :
   1. Cash/sh = $2.88
9. $TCON – TRACON Pharmaceuticals, Inc. :
   1. Cash/sh = $1.79
10. $TRVN – Trevena, Inc. :
    1. Cash/sh = $0.94
11. $VBLT – Vascular Biogenics Ltd. :
    1. Cash/sh = $1.71
12. $VXRT – Vaxart, Inc. :
    1. Cash/sh = $2.96

Please also Share Your Favorite Stocks currently Trading Below Cash (TBC) here in this Topic as well, ok?

#TradingBelowCash #TBC #StockPicks #Stock #Market #Trading

[Michael DeVries]

The following are the Stock Symbols on my Watchlist to Buy if/when they bottom out at the Buy at Price Targets listed below for the Week of 11/19/2018 – 11/23/2018:

1) ACHV – Achieve Life Sciences, Inc. – Trading Below Cash
a. Buy at < ~ $1.70
b. Sell at >~ $5.20
c. Catalysts:
1. NA – In Vitro And Ex Vivo Anti-Inflammatory Activities Of Salmon Polar Lipids; 20181031; 20181130; https://ClinicalTrials.gov/show/NCT03603769
2. Phase 2 – Trial of Cytisine in Adult Smokers; 20190512; 20190630; https://ClinicalTrials.gov/show/NCT03709823

2) OXBR – Oxbridge Re Holdings Limited – Trading Below Cash
a. Buy at < ~ $1.00
b. Sell at >~ $2.50

3) ADXS – Advaxis, Inc. – Trading Below Cash
a. Buy at < ~ $0.44
b. Sell at >~ $1.15
c. Catalysts:
1. Phase 1Phase 2 – ADXS11-001 High Dose HPV+ Cervical Cancer; 20181201; 20181231; https://ClinicalTrials.gov/show/NCT02164461
2. Phase 2 – A Study of Pemetrexed Maintenance With or Without ADXS11-001 Immunotherapy in Patients With Human Papillomavirus Positive (HPV+), NSCLC Following First-Line Induction Chemotherapy; 20190301; 20190331; https://ClinicalTrials.gov/show/NCT02531854
3. Phase 1Phase 2 – Dose Escalation Study of ADXS31-164 in Subjects With HER2 Expressing Solid Tumors; 20180801; 20181231; https://ClinicalTrials.gov/show/NCT02386501
4. Phase 2 – ADXS 11-001 Vaccination Prior to Robotic Surgery, HPV-Positive Oropharyngeal Cancer; 20180801; 20190831; https://ClinicalTrials.gov/show/NCT02002182
5. Phase 1Phase 2 – ADXS31-142 Alone and in Combination With Pembrolizumab (MK-3475) in Patients With Prostate Cancer – KEYNOTE-046; 20190401; 20191231; https://ClinicalTrials.gov/show/NCT02325557
6. Phase 2 – Phase 2 Study of ADXS11-001 in Subjects With Carcinoma of the Anorectal Canal; 20200301; 20220331; https://ClinicalTrials.gov/show/NCT02399813
7. Phase 3 – Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer; 20200601; 20210630; https://ClinicalTrials.gov/show/NCT02853604
8. Phase 1Phase 2 – Phase 1-2 Study of ADXS11-001 or MEDI4736 Alone or Combo In Cervical or HPV+ Head & Neck Cancer; 20190701; 20191231; https://ClinicalTrials.gov/show/NCT02291055
9. Phase 1 – Expressing Personalized Tumor Antigens Study; 20190901; 20200930; https://ClinicalTrials.gov/show/NCT03265080

What do you think about these Stock Picks to Buy at these Price Targets?

What other Stock Symbols do you all think are the Best Stocks < ~ $10 to Buy next week, 11/19/2018 – 11/23/2018, and Why?

Disclaimer

[Michael DeVries]

We have Subscribed to @IncredibleTrade‘s service at: https://incredibletrades.com/ for coming up on two (2) years now.

The following are just some of the Great Calls from @IncredibleTrade with which we have Made Money!:

• Another Great Call by @IncredibleTrade => “20181101 IT LONG $SLS 1.86 stop 1.50, PT 2.50” !
  • We were In 11/1/2018 2:47 PM @ $1.80, Out 11/9/2018 9:21 AM @ $2.41 for a >32% ROI in < 8 Days!

Thank you again @IncredibleTrade !

We would Highly Recommend that you Join Us Making Money with @IncredibleTrade‘s service at: https://incredibletrades.com/

 

[Michael DeVries]

Machine Learning related Articles:

• A Handy Way to Think About Machine Learning => https://www.the-vital-edge.com/handy-machine-learning/
• How machine learning drives big business benefits => http://techgenix.com/machine-learning-business-benefits/

Please Reply with any articles regarding or related to Machine Learning that you feel may be of interest and benefit to others, ok?

… and let’s discuss them all herein, ok?

I hope this all helps and Have a Great Day!

– Michael S. DeVries

[Michael DeVries]

Has anyone out there used Microsoft Azure Machine Learning?

What did you think of Microsoft Azure Machine Learning to produce Machine Learning solutions?

What types of problems have you solved? / questions have you answered using Microsoft Azure Machine Learning?

Have you used Microsoft Azure Machine Learning Studio?
… and if so, then what did you think of Microsoft Azure Machine Learning Studio as an IDE to develop and test your Machine Learning solutions?
… if not, then what is your favorite IDE(s) for developing and testing yourMachine Learning solutions? and Why?

Thank you for any of your responses and/or assistance in these regards and Have a Great Day!

– Michael S. DeVries

References:

• Microsoft Azure Machine Learning Overview => https://azure.microsoft.com/en-us/overview/machine-learning/
• Microsoft Azure Machine Learning Studio => https://azure.microsoft.com/en-us/services/machine-learning-studio/

[Michael DeVries]

Articles – 20181029:

1) It’s time to stop making “ Microservices” the goal of modernization. => https://medium.com/@rbarcia/its-time-to-stop-making-microservices-the-goal-of-modernization-71758b400287
2) Deploying a Secure Cloud Native Microservices Platform => https://www.linkedin.com/pulse/deploying-secure-cloud-native-microservices-platform-pratik-jain/
3) Employment: Automation, chatbots, social media to sharpen hiring process in 2018 => https://www.firstpost.com/business/employment-automation-chatbots-social-media-to-sharpen-hiring-process-in-2018-4261171.html
4) Four Cutting-Edge Technologies Manufacturers Need To Create A Dynamic Supply Chain => https://www.forbes.com/sites/sap/2018/10/20/four-cutting-edge-technologies-manufacturers-need-to-create-a-dynamic-supply-chain/

5) Machine Learning And Data — Where You’d Least Expect It => https://www.forbes.com/sites/ciocentral/2018/10/30/machine-learning-data-where-youd-least-expect-it/?utm_content=79161334&utm_medium=social&utm_source=twitter#78431bbf9871

6) How machine learning drives big business benefits => http://techgenix.com/machine-learning-business-benefits/

Articles – 20181105:

7) Lockheed Martin extends additive manufacturing to key spacecraft components => https://spacenews.com/lockheed-martin-extends-additive-manufacturing-to-key-spacecraft-components/?utm_content=79341405

8) What The Future Of IoT And 5G May Look Like => https://www.forbes.com/sites/forbestechcouncil/2018/11/01/what-the-future-of-iot-and-5g-may-look-like/?utm_content=79341396

9) AI, 3D printing, and IoT are here — but what’s next? => https://techwireasia.com/2018/10/ai-3d-printing-and-iot-are-here-but-whats-next/?utm_content=79354717

Articles – 20181119 – 1

• Your Face is Your Boarding Pass … => https://finance.yahoo.com/news/face-boarding-pass-jetblue-introduces-184100203.html
• Digital strategy: The four fights you have to win => https://www.mckinsey.com/business-functions/digital-mckinsey/our-insights/digital-strategy-the-four-fights-you-have-to-win?cid=soc-app
• People do not quit companies, managers, or leaders – they quit organizational cultures. Here’s why => https://christielindor.blogspot.com/2017/10/people-do-not-quit-companies-managers.html
• Intelligent Automation Technologies To Have Most Impact On Digital Businesses in 2019 => https://automationedge.com/intelligent-automation-technologies-to-have-most-impact-on-digital-businesses-in-2019/
• The Three Layers of Digital Transformation => https://stories.platformdesigntoolkit.com/the-three-layers-of-digital-transformation-b7fdcb7effe9
• Netflix Conductor: A microservices orchestrator => https://medium.com/netflix-techblog/netflix-conductor-a-microservices-orchestrator-2e8d4771bf40
• New – Train Custom Document Classifiers with Amazon Comprehend => http://netofeverything.blogspot.com/2018/11/new-train-custom-document-classifiers.html
• Why People Are Saying ‘Thank You’ to Chatbots => https://www.entrepreneur.com/article/322096
• The Self-Taught Data Scientist Curriculum => http://www.data-mania.com/blog/self-taught-data-scientist-curriculum/
• Mapping the AI Transformation Journey In Your Organization => https://www.forbes.com/sites/cognitiveworld/2018/09/10/mapping-the-ai-transformation-journey-in-your-organization/#3e53a6f25925
• AI And Automation In The Cloud — Seizing The Moment For Digital Transformation => https://www.forbes.com/sites/forbestechcouncil/2018/08/23/ai-and-automation-in-the-cloud-seizing-the-moment-for-digital-transformation/#140c76ce4c99
• State of AI in the Enterprise, 2nd Edition => https://www2.deloitte.com/insights/us/en/focus/cognitive-technologies/state-of-ai-and-intelligent-automation-in-business-survey.html
• Humanizing Technology Through Chatbots =>
• Pushing the limits of RPA with AI => https://www.capgemini.com/2018/11/pushing-the-limits-of-rpa-with-ai/
• Machine Learning in Organization: First Steps => https://martinhiesboeck.com/2018/08/08/machine-learning-in-organization-first-steps/
• The Intelligent Automation Revolution: From Robotic Process Automation To Cognitive Automation => https://www.forbes.com/sites/kpmg/2018/10/24/the-intelligent-automation-revolution-from-robotic-process-automation-to-cognitive-automation/#c2b5fa86da21
• How automation is changing data science and machine learning => https://betanews.com/2018/11/08/how-automation-is-changing-data-science-and-machine-learning/

[Michael DeVries]

#Bullish #Stocks currently #TradingBelowBook (#TBB ) as of 10/19/2018 include:

1. $ATOS – Atossa Genetics Inc. :
   1. Book/sh = $1.98
2. $CHFS – CHF Solutions, Inc. :
   1. Book/sh = $1.96
3. $CLDX – Celldex Therapeutics, Inc. :
   1. Book/sh = $0.87
4. $DCAR – DropCar, Inc. :
   1. Book/sh = $2.00
5. $HMNY – Helios and Matheson Analytics Inc. :
   1. Book/sh = $113.81
6. $IPWR – Ideal Power Inc. :
   1. Book/sh = $0.60
7. $JAGX – Jaguar Health, Inc. :
   1. Book/sh = $1.23
8. $KOOL – Cesca Therapeutics Inc. :
   1. Book/sh = $0.67
9. $OSN – Ossen Innovation Co., Ltd. :
   1. Book/sh = $15.50
10. $OVAS – OvaScience, Inc. :
    1. Book/sh = $1.40
11. $RTTR – Ritter Pharmaceuticals, Inc. :
    1. Book/sh = $2.11
12. $RXII – RXi Pharmaceuticals Corporation :
    1. Book/sh = $0.80
13. $TNXP – Tonix Pharmaceuticals Holding Corp. :
    1. Book/sh = $1.89
14. $XGTI – xG Technology, Inc. :
    1. Book/sh = $0.69

Please also Share Your Favorite Stocks currently Trading Below Book (TBB) here in this Topic as well, ok?

[Michael DeVries]

Bullish Stocks currently Trading Below Cash (TBC) as of 10/19/2018 include:

1. $ATOS – Atossa Genetics Inc. :
   1. Cash/sh = $1.71
2. $CLDX – Celldex Therapeutics, Inc. :
   1. Cash/sh = $0.70
3. $DCAR – DropCar, Inc. :
   1. Cash/sh = $0.88
4. $HMNY – Helios and Matheson Analytics Inc. :
   1. Cash/sh = $0.02
5. $OVAS – OvaScience, Inc. :
   1. Cash/sh = $1.55
6. $RTTR – Ritter Pharmaceuticals, Inc. :
   1. Cash/sh = $2.81
7. $TCON – TRACON Pharmaceuticals, Inc. :
   1. Cash/sh = $1.79
8. $TRVN – Trevena, Inc. :
   1. Cash/sh = $0.85
9. $VXRT – Vaxart, Inc. :
   1. Cash/sh = $3.24

Please also Share Your Favorite Stocks currently Trading Below Cash (TBC) here in this Topic as well, ok?

[Michael DeVries]

The Rising Scope Of Conversational Interfaces Using LMS – Chatbots In The Workplace => https://elearningindustry.com/chatbots-in-the-workplace-rising-scope-conversational-interfaces-using-lms

What Roles do you believe that Conversational Interfaces / Chatbots may play in the workplace? and Why?

What Use Cases do you believe offer the greatest ROI (Return On Investment) for Conversational Interfaces / Chatbots in the workplace? and Why?

Let’s discuss this all herein, ok?

I hope this all helps and Have a Great Day!

– Michael S. DeVries

[Author]

Posts